USP standards for infant formula
This article was originally published in The Tan Sheet
Executive SummaryThe U.S. Pharmacopeia proposes adding to the Food Chemicals Codex three nucleotides found in breast milk and commonly added to infant formula, and two DHA oils. USP will add the new voluntary industry standards to the codex following a three-month public comment period ending March 31 to enhance the quality and safety of infant formulas and functional foods. The proposed nucleotide standards - for disodium 5'-uridylate, 5'-adenylic acid and 5'-cytidylic acid - designate the identity, purity and impurities of the ingredients and validated test methods, USP says. The proposed DHA standards are for DHA algal oil, crypthecodinium type and DHA algal oil, schizochytrium type. During a Jan. 14 interview, USP Director of Food Standards Markus Lipp said the standards allow marketers to approach suppliers with a set of minimum requirements for products, and allow suppliers to promote their adherence to the standards to set themselves apart from competitors
You may also be interested in...
The EU network of health technology assessment bodies says it is seeing the benefit of systematically involving patients when companies approach it for early scientific advice on evidence generation.
As stockpiles of Ebola vaccine are being built up around the world, Médecins sans Frontières has said more action is needed to ensure sufficient numbers of vaccinations are available for use in current and future outbreaks.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced November 2019.